Siva Vijayakumar Tharumasivam | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Siva Vijayakumar Tharumasivam | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Dr.Siva Vijayakumar Tharumasivam, Dhanalakshmi Srinivasan University, India

Dr. T. Siva Vijayakumar (M.Sc., Ph.D., D.Sc. Honoris Causa) is a dedicated academician and accomplished researcher in Biotechnology, currently serving as Associate Dean – HRDC at Dhanalakshmi Srinivasan University, Tamil Nadu. With a dual role as Flying Officer in the Indian NCC (Airwing), his career embodies leadership in both academia and service. Dr. Vijayakumarโ€™s dynamic research covers aquatic toxicology, nanobiotechnology, neurodegenerative diseases, and regenerative medicine. He has guided numerous students in pioneering scientific exploration and has authored over 48 publications in reputed journals. A passionate mentor, he integrates innovative methodologies in research and education, ensuring his students gain holistic scientific exposure. His expertise has earned national recognition, contributing to scientific knowledge and societal progress. Committed to sustainable solutions, his work addresses pressing environmental and health challenges through nanoscience and biotechnology. His impactful contributions continue to inspire emerging scientists and institutions alike. ๐ŸŒฟ๐Ÿ”ฌ๐Ÿ‡ฎ๐Ÿ‡ณ

Publication Profile

google scholar

Education

Dr. Siva Vijayakumar pursued his Master of Science (M.Sc.) in Biotechnology, followed by a Doctor of Philosophy (Ph.D.), with an academic journey grounded in molecular biology, toxicology, and applied nanoscience. Recognized for his significant contributions to the field, he was conferred with a Doctor of Science (D.Sc.) Honoris Causa by the International Agency for Standards and Rating in 2021. His education reflects a strong emphasis on multidisciplinary integration, blending core biological sciences with technological innovations. He has continually upgraded his scientific expertise through hands-on research, workshops, and training programs. His educational foundation has enabled him to bridge theoretical knowledge with practical applications in fields such as drug delivery, aquatic environmental health, and regenerative biology. Through his academic pursuits, he has mentored future scientists, instilling a rigorous yet innovative approach to biotechnology. ๐Ÿ“˜๐Ÿงฌ๐ŸŽ“

Experience

Dr. Vijayakumar has over a decade of teaching and research experience in biotechnology. Currently, he holds the position of Associate Dean – Human Resource Development Centre (HRDC) at the Department of Biotechnology, Dhanalakshmi Srinivasan University, Tamil Nadu. He also serves as a Flying Officer and Associate NCC Officer (3TN Air Squadron NCC, Trichy), promoting discipline and patriotism among students. His academic leadership spans curriculum development, research mentoring, and interdisciplinary program coordination. He has played a pivotal role in conducting national workshops, guiding research scholars, and collaborating on funded projects. His administrative experience has fortified institutional growth through strategic planning and research integration. As a faculty member and leader, heโ€™s known for fusing technology with biological sciences, emphasizing innovation, and cultivating global scientific perspectives among students. ๐Ÿงช๐Ÿ“šโœˆ๏ธ

Awards and Honors

Dr. Siva Vijayakumar has been honored with several prestigious awards recognizing his excellence in research and education. Notable among them is the Guru Samman Award 2025 ๐Ÿง‘โ€๐Ÿซ by AISPCPA, Bengaluru, and the Innovative Research Award 2023 ๐Ÿง  by Rover Agricultural College, Perambalur. In 2021, he received the Honorary Doctorate in Biotechnology (D.Sc.) ๐ŸŽ“ and the Research Excellence Award ๐Ÿ† by the Institute of Scholars. His early research acumen earned him the Young Investigator Award 2020 ๐Ÿ” from DERO and the Best Young Scientist Award 2017 ๐Ÿงฌ by PEARL Foundation. These accolades reflect his dedication to advancing biotechnology, inspiring students, and contributing meaningfully to scientific society. His recognition across both academic and service domains illustrates a career committed to innovation, leadership, and impact. ๐ŸŒŸ๐Ÿ…

Research Focus

Dr. Vijayakumar’s primary research revolves around Aquatic Toxicology and Nanobiotechnology, emphasizing the impact of engineered nanomaterials (ENMs) on aquatic ecosystems. He investigates the toxicity, transport, bioaccumulation, and ecological impact of nanoparticles, including their genotoxic and ecotoxic consequences. His research extends to drug delivery systems, exploring biocompatibility, host responses, and novel therapeutics for neurodegenerative diseases and tissue regeneration. His interdisciplinary approach bridges molecular biology, environmental science, and materials engineering. A strong advocate for eco-safe nanotechnology, he integrates in vitro, in vivo, and computational models to assess risk and functionality. His team engages in animal model studies, molecular simulations, and regenerative biomaterial design, contributing to innovations in environmental health and biomedical applications. His vision is to foster sustainable and safe biotechnological advancements for future healthcare and environmental well-being. ๐ŸŒŠ๐Ÿงช๐Ÿง 

Publication Top Notes

  1. ๐Ÿงฌ Exploring Piperine as a Potential Treatment for Polycystic Ovarian Syndrome: Insights from In-silico Docking Studies (2024)

  2. ๐ŸŸ Toxicity Assessment on Haematology and Enzymological Alterations of Alโ‚‚Oโ‚ƒ Nanoparticles Exposed Freshwater Fish (2024)

  3. ๐ŸŒฟ Exploring Potential Anti-aging Compounds and Binding Affinity of Resveratrol with hTERT Gene (2024)

  4. ๐Ÿง  Computational Analysis of Anti-Alzheimerโ€™s Efficacy of Myristicin from Nutmeg (2024)

  5. ๐Ÿงซ Characterization of Novel Antimicrobial Peptides from Clarias Batrachus (2024)

  6. ๐Ÿ’ง Carbon Nanoparticles Fabricated Microfilm for Microplastics Filtration (2023)

  7. ๐Ÿฉน Functional 2D Graphene Oxide in the Wound Healing Process (2023)

  8. ๐Ÿฆ Probiotics-Infused Withania Somnifera for Shrimp Development (2023)

  9. ๐Ÿงช Fabrication of Silver Nanoparticles using Illicium Verum and Its Anti-bacterial Activity (2023)

  10. ๐Ÿ‡ Pharmacological Properties and Mode of Action of Quercetin: A Bioactive Flavonoid (2023)

  11. ๐ŸŒฑ Anti-inflammatory Activity of Ocimum Tenuiflorum-loaded Chitosan Nanoparticles (2023)

  12. ๐Ÿงฌ Complete Overview of Enzymatic Responses in Nanoparticle-Stressed Fish Models (upcoming)

William Agbozo | Biochemistry, Genetics and Molecular Biology | Best Research Article Award

William Agbozo | Biochemistry, Genetics and Molecular Biology | Best Research Article Award

William Agbozo, Morehouse School of Medicine, Atlanta, GA 30310, USA. United States

William Kwaku Agbozo is a passionate Ghanaian biomedical researcher specializing in molecular and cell biology, particularly in the context of hemolysis-related complications in sickle cell disease and cerebral malaria. With a strong academic foundation from the University of Ghana, he has cultivated expertise through interdisciplinary training in physiology, biochemistry, and molecular sciences. Currently serving as a Research Scholar at Morehouse School of Medicine, Atlanta, he brings his research to life by utilizing advanced genomics and proteomics tools in both animal and human studies. His work has yielded peer-reviewed publications and international presentations, reflecting a commitment to translational science aimed at uncovering therapeutic targets. William has also made significant contributions as a lecturer at Central University, Ghana, mentoring students and guiding research projects. His career is driven by a desire to bridge clinical gaps in infectious and genetic diseases, focusing on real-world biomedical challenges in Africa and beyond.

Publication Profile

orcid

Education

William Agbozoโ€™s academic journey began at the University of Ghana, where he earned his Bachelor of Science in Biochemistry (2008โ€“2012). He continued at the same institution to pursue a Master of Philosophy in Physiology (2013โ€“2015), equipping him with in-depth knowledge of human physiological mechanisms. Motivated by a growing interest in translational biomedical research, he embarked on a PhD in Molecular and Cell Biology (2018โ€“2024, Viva pending), also at the University of Ghana. Throughout his academic path, William has maintained a strong interdisciplinary focusโ€”integrating molecular biology, physiology, and cell biology with practical research on diseases like sickle cell and malaria. His PhD was conducted under the prestigious West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), supported by multiple international grants, where he gained valuable skills in omics technologies and disease modeling. His academic training reflects both scientific rigor and a deep-rooted commitment to addressing health burdens in Africa.

Experience

William Agbozo has over six years of academic and research experience. From 2017 to 2023, he worked as a Lecturer at the School of Medicine and Health Sciences, Central University, Accra, where he taught undergraduate physiology and supervised research and academic writing. In 2023, he transitioned to the Morehouse School of Medicine in Atlanta, USA, as a Research Scholar in the Department of Microbiology, Biochemistry & Immunology. At Morehouse, he is engaged in conceptualizing research ideas, contributing to grant proposals, and conducting laboratory experiments in molecular and translational research. He also leads data analysis and presents at major scientific meetings. His work spans across both African and U.S.-based biomedical institutions, reinforcing a global collaborative perspective. His experience reflects a balance of education, research, mentorship, and scientific communication, aimed at producing actionable insights for health systems managing genetic and infectious diseases.

Awards and Honors

William Agbozo has received several prestigious awards in recognition of his academic excellence and impactful research. He was awarded a PhD Fellowship (2018โ€“2024) from the West African Centre for Cell Biology of Infectious Pathogens (WACCBIP) under the World Bank African Centres of Excellence (ACE) initiative. Between 2019 and 2023, he secured research funding support from the Sickle Cell Disease Genomics Network of Africa (SickleGenAfrica), funded by the National Heart, Lung, & Blood Institute (U54HL141011). His scientific aptitude also earned him a place in the US Exchange Visitor Program as a research scholar at Morehouse School of Medicine (2023โ€“2025), under the National Institute of Neurological Disorders and Stroke (R01NS125775). These honors reflect both his research potential and his growing international reputation in the fields of sickle cell disease and molecular medicine. They have empowered him to explore groundbreaking discoveries using both human samples and experimental models.

Research Focus

William Agbozoโ€™s research centers on the molecular mechanisms of hemolysis-mediated injury in diseases such as sickle cell disease (SCD) and human cerebral malaria (HCM). His work investigates how excess free heme contributes to acute kidney injury (AKI) and brain damage, using humanized sickle cell mouse models and post-mortem human samples. He applies cutting-edge genomics and proteomics to map signaling pathways and identify biomarkers that may serve as protective or therapeutic targets. Through his research, William aims to bridge molecular biology with translational applications, developing insights that could lead to novel treatments or interventions. His work is especially impactful in regions heavily burdened by malaria and genetic blood disorders. By collaborating across institutions in Ghana and the United States, he brings an interdisciplinary and international lens to pressing biomedical problems affecting both African and global populations.

Publication Top Notes

๐Ÿ“„ Hydroxyurea Mitigates Heme-Induced Inflammation and Kidney Injury in Humanized Sickle Cell Mice. (2025)
๐Ÿ“„ Circulating biomarkers associated with pediatric sickle cell disease. (2024)
๐Ÿ“„ Assessing knowledge of sickle cell disease and health beliefs on premarital genetic screening among healthcare trainees at a tertiary institution: A crossโ€sectional study. (2023)
๐Ÿ“„ Sociodemographic and medical characteristics of liver cirrhosis deaths in a Ghanaian tertiary hospital. (2022)
๐Ÿ“„ Phosphomolybdenum Blue Detection โ€“ A Review of Characteristics, Achievements, Challenges and Future Prospects. (2020)
๐Ÿ“„ Frequencies and ethnic distribution of ABO and RhD blood groups in the Volta region of Ghana, towards effective blood bank services. (2022)
๐Ÿ“„ Frequency of ABO/Rhesus (D) blood groupings and ethnic distribution in the Greaterโ€Accra region of Ghana, towards effective blood bank inventory. (2019)
๐Ÿ“„ Neuregulin-1 attenuates hemolysis-mediated kidney injury in humanized sickle cell mice. (Submitted)

Santina Bruzzone | Genetics and Molecular Biology | Best Researchers Award

Santina Bruzzone | Genetics and Molecular Biology | Best Researchers Award

Santina Bruzzone,Universitร  di Genova,Italy

Santina Bruzzone is a Full Professor of Biochemistry at the University of Genova, Italy. She was born on February 21, 1972, in Genova, Italy. Her research focuses on the role of NAD+ and NAD+-converting enzymes in inflammation and cancer.

Publication Profile

Scopus

Education

Santina Bruzzone completed her high school education at Liceo Scientifico L. Lanfranconi in Genova, Italy, from 1986 to 1991. She then earned her degree in Biology from the University of Genova, graduating cum laude with a score of 110/110 in 1996. She received her Ph.D. in Biotechnology applied to Pharmacology and Cellular and Molecular Biotechnology applied to Biomedicine from the University of Milano from 1996 to 2000.

Experince

Santina Bruzzone worked as a postdoctoral researcher at the Department of Experimental Medicine (DIMES)โ€“Section of Biochemistry, University of Genova, from January to March 2001. She then worked as a postdoctoral researcher at the Department of Pharmacology, University of Minnesota, from April to December 2001. She returned to the University of Genova as a postdoctoral researcher from 2002 to 2005 and later became an Assistant Professor of Biochemistry from 2005 to 2016. She was promoted to Associate Professor of Biochemistry from 2016 to 2021 and became a Full Professor of Biochemistry in 2021.

Award and Honors

Santina Bruzzone received several awards and honors, including the Fellowship for training abroad from Consorzio Interuniversitario Biotecnologie (CIB) in 2001, the Fellowship for training abroad from the University of Genova in 2001, and the Faculty Research Visit Grant from DAAD (German Academic Exchange Service) in 2013.

Research Focus

Santina Bruzzone’s research focuses on the role of NAD+ and NAD+-converting enzymes in inflammation and cancer. Her work explores the molecular mechanisms underlying the regulation of NAD+ metabolism and its impact on cellular processes such as energy metabolism, cell signaling, and cell death.

Publications

1. ๐ŸŒŸ CD38 and ADP-ribosyl cyclase catalyze the synthesis of a dimeric ADP-ribose that potentiates the Calcium-mobilizing activity of Cyclic ADP-ribose. (1997)
2. ๐ŸŒŸ Ectocellular CD38-catalyzed synthesis and intracellular Ca2+-mobilizing activity of Cyclic ADP-ribose. (1998)
3. ๐ŸŒŸ Expression of CD38 increases intracellular calcium concentration and reduces doubling time in HeLa and 3T3 cells. (1998)
4. ๐ŸŒŸ The transmembrane glycoprotein CD38 is a catalytically active transporter responsible for generation and influx of the second messenger Cyclic ADPribose across membranes. (1998)
5. ๐ŸŒŸ Dimeric and tetrameric forms of catalytically active transmembrane CD38 in transfected HeLa cells. (1998)
6. ๐ŸŒŸ Ligand-induced internalization of CD38 results in intracellular Ca2+ mobilization. (1999)
7. ๐ŸŒŸ Topology of CD38. (2000)
8. ๐ŸŒŸ Extracellular cyclic ADP-ribose increases intracellular free calcium concentration and stimulates proliferation of human hemopoietic progenitors. (2000)
9. ๐ŸŒŸ G(s) protein dysfunction in allergen-challenged human isolated passively sensitized bronchi. (2000)
10. ๐ŸŒŸ Connexin 43 hemichannels mediate Ca2+-regulated transmembrane NAD+ fluxes in intact cells. (2001)
11. ๐ŸŒŸ Extracellular Cyclic ADP-ribose potentiates Ach-induced contraction in bovine tracheal smooth muscle. (2001)
12. ๐ŸŒŸ Human CD38 and its ligand CD31 define a unique lamina propria T lymphocyte signaling pathway. (2001)
13. ๐ŸŒŸ Paracrinally stimulated expansion of early human hemopoietic progenitors by stroma-generated cyclic ADP-ribose. (2001)
14. ๐ŸŒŸ Paracrine roles of NAD+ and Cyclic ADP-ribose in increasing intracellular calcium and enhancing cell proliferation of 3T3 fibroblasts. (2001)
15. ๐ŸŒŸ Autocrine abscisic acid mediates the UV-B-induced inflammatory response in human granulocytes and keratinocytes. (2012)
16. ๐ŸŒŸ ABA says NO to UV-B: a universal